List of Included studies. حسب Zahra Tajik (20752452)

الموضوعات:

Flow chart of the literature search for studies included in meta-analysis. حسب Zahra Tajik (20752452)

الموضوعات:

The search strategy in three databases. حسب Zahra Tajik (20752452)

الموضوعات:

Summary of meta-analysis results to compare visfatin level before and after NSPT among cases with periodontitis and T2DM. حسب Zahra Tajik (20752452)

الموضوعات:

The comparison of GCF visfatin level before and three months after NSPT among cases with periodontitis. حسب Zahra Tajik (20752452)

الموضوعات:

A summary of the included study characteristics. حسب Zahra Tajik (20752452)

الموضوعات:

NIH score. حسب Zahra Tajik (20752452)

الموضوعات:

The comparison of saliva visfatin level before and three months after NSPT among cases with periodontitis. حسب Zahra Tajik (20752452)

الموضوعات:

The comparison of GCF visfatin level before and three months after NSPT among cases with periodontitis and T2DM. حسب Zahra Tajik (20752452)

الموضوعات:

List of excluded studies. حسب Zahra Tajik (20752452)

الموضوعات:

Sensitivity and subgroup analysis between higher TV watching time and cognitive scores. حسب Hattapark Dejakaisaya (22238613)

الموضوعات:

Sensitivity and subgroup analysis of conventional meta-analysis of TV watching time and risk of cognitive impairment. حسب Hattapark Dejakaisaya (22238613)

الموضوعات:

The main characteristics of the 35 studies included in the systematic review categorized by their study designs. حسب Hattapark Dejakaisaya (22238613)

الموضوعات:

DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF حسب Sofia Schaeffer (20379954)

"…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …"

DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF حسب Sofia Schaeffer (20379954)

"…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …"

DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF حسب Sofia Schaeffer (20379954)

"…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …"

DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF حسب Sofia Schaeffer (20379954)

"…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …"

Seven forecast scenarios. حسب Ryan P. Thombs (9138968)

"…We find that a decrease in expenditures has a larger effect on decreasing energy consumption than an increase in expenditures does on increasing consumption. …"

Forecast for each scenario, 2023-2032. حسب Ryan P. Thombs (9138968)

"…We find that a decrease in expenditures has a larger effect on decreasing energy consumption than an increase in expenditures does on increasing consumption. …"

Supplementary Material for: Adjunctive active vitamin D (AVD) decreases kidney function during treatment of secondary hyperparathyroidism (SHPT) with extended-release calcifediol (... حسب figshare admin karger (2628495)